Literature DB >> 6232999

T-suppressor cell chronic lymphocytic leukemia. Phenotypic characterization by monoclonal antibodies.

K Bakri, E Z Ezdinli, L P Wasser, T Han, T Sinclair, S Singh, H Ozer, J Minowada.   

Abstract

A patient with long standing seropositive rheumatoid arthritis developed lymphocytosis which phenotypically involved the cytotoxic/suppressor T-lymphocyte population. There are 10 reported instances of this new disease entity described as "chronic T-cell lymphocytosis with neutropenia" or "chronic suppressor T-cell lymphocytic leukemia." The disease is characterized by hepatosplenomegaly, neutropenia, and the frequent presence of rheumatoid factor without clinical evidence of rheumatoid arthritis. Splenectomy in our patient, as well as in other instances where undertaken, has been ineffective in alleviating the neutropenia. The peripheral blood lymphocytes in our patient were OKT-3+, OKT-5+, OKT-8+, OKT-11+, cALL-, OKT-6-, TdT-. They possessed ADCC but no NK activity and did not suppress PWM-induced B-cell differentiation in spite of the presence of Fc receptor for IgG. Since the lymphocytosis of OKT-8+ cells appears to be clonal, it is suggested that the disease be designated chronic suppressor T-cell lymphocytic leukemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232999     DOI: 10.1002/1097-0142(19840715)54:2<284::aid-cncr2820540217>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  1 in total

1.  Correlated ultrastructural and immunological findings in CD8+ and CD4+ peripheral T-cell lymphomas.

Authors:  F Osculati; S Cinti; M Reynès; G Balercia; C Canon; V Tricottet; D Dantchev; G Mathé
Journal:  Med Oncol Tumor Pharmacother       Date:  1988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.